RxDoctor Payments Data

Loida Buaquina, APRN

Family · Spring Hill, FLNPI 1851924708

Payments from drug & device makers

$193in general payments, 2019–2025

Across 9 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$36
  • Edwards Lifesciences$33
  • Si-bone, Inc.$25
  • Tactile Systems Technology Inc$24
  • Dexcom, Inc.$24
  • Merck$20
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$193 in reported general payments places this provider in the 35th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$9,674
Medicare patients
50
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$34,453
EliquisApixaban25$23,204
Breo ElliptaFluticasone/Vilanterol32$15,975
XareltoRivaroxaban12$12,752
MyrbetriqMirabegron12$9,499
Fluticasone-SalmeterolFluticasone Propion/Salmeterol59$8,103
Wixela InhubFluticasone Propion/Salmeterol70$6,040
Dabigatran EtexilateDabigatran Etexilate Mesylate30$4,730
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$4,719
Gabapentin146$3,891
Duloxetine Hcl115$3,563
Atorvastatin Calcium304$2,817
Albuterol Sulfate HfaAlbuterol Sulfate95$2,817
Levothyroxine Sodium181$2,448
Lidocaine14$1,695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$15$50,42868 claims
PfizerEliquis$36$23,20425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 14,618 family providers in Florida.

Other family in Spring Hill

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →